Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.

Introduction: Since the beginning of the pandemic in 2020, COVID-19 has changed the medical landscape. International recommendations for localized prostate cancer (PCa) include deferred treatment and adjusted therapeutic routines.

Materials And Methods: To longitudinally evaluate changes in PCa treatment strategies in urological and radiotherapy departments in Germany, a link to a survey was sent to 134 institutions covering two representative baseline weeks prior to the pandemic and 13 weeks from March 2020 to February 2021.

To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic.

Introduction: After the outbreak of COVID-19 unprecedented changes in the healthcare systems worldwide were necessary resulting in a reduction of urological capacities with postponements of consultations and surgeries.

Material And Methods: An email was sent to 66 urological hospitals with focus on robotic surgery (RS) including a link to a questionnaire (e.g.

Stones of the upper urinary tract. Update on minimal-invasive endourological treatment.

So far extracorporal shockwave lithotripsy (SWL) is the treatment of choice for upper urinary tract stones. Since the introduction of new minimal-invasive endourological procedures, such as retrograde flexible uretero-renoscopy (fURS) and minimal-invasive percutaneous nephrolithotomy (Mini-Perc), alternative treatment modalities are available, which show enhanced stone-free rates and decreased treatment morbidity even in unfavorable stone localizations of the lower calix and calyceal diverticulum stones. In experienced hands modern endourological approaches are suitable as first-line treatment of upper urinary tract stones.